Job description
Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters. The PositionAs the Global Business Process Specialist for Record to Report – Management Accounting, you are part of the Global Business Process Management Organization in Roche Services & Solutions. Roche is running an enterprise-wide business transformation program that will harmonize all core end-to-end processes across the Roche enterprise and enable their execution from one standardized IT system template. In this role, you will govern deployment of financial core processes of the Aspire Global Template in the E2E process area Record to Report Management Accounting. Furthermore, you will be responsible for the continuous global harmonization, standardization and automation of the Management Accounting processes including the global process design and its delivery to various stakeholders. You will work in close collaboration with representatives from various business functions from Finance, Commercials, Supply Chain and IT, cross divisionally (Pharma and Diagnostics).
Responsibilities & skills
Education
Strong influencing skills and ability to work in complex global networks with international teams and stakeholder communities (Business and IT). Exceptional organizational skills and time management, ability to prioritize multiple tasks and goals to ensure timely and high quality accomplishment of such
Experience
Experience in Management Accounting/ Financial Controllin. Understanding of R2R Management Accounting processes and its relation to other process areas. Experience in SAP Finance (Controlling/ Management Accounting)
Ready to apply?
Sign in and make sure your profile and resume are up to date.
Roche
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies.We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers.We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably.We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries.
View company profile